LAWRENCE STEINMAN, Director at Atreca, holds 38.46K shares in BioAtla (Ticker: BCAB), holds 1.33M shares in Pasithea Therapeutics Corp (Ticker: KTTA), holds 48.13K shares in 180 Life Sciences (Ticker: ATNF). Most recently, LAWRENCE STEINMAN Bought ― shares of BioAtla on Dec 19, 2023 for an estimated value of 41.00K.